Clinical Trials Directory

Trials / Completed

CompletedNCT05219539

Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy

Outcomes of the National Advanced Training Program for Laparoscopic Radical Gastrectomy: a Survey Based on Follow-up Questionnaire

Status
Completed
Phase
Study type
Observational
Enrollment
1,355 (actual)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study aims to evaluate the outcomes of the advanced training program for laparoscopic radical gastrectomy (ATP-LRG). The research subjects are the trainees who participated in this training program.

Detailed description

Written informed consent is not required because of the observational and anonymous nature of this study. ATP-LRG is a national training program carried out by Fujian Medical University Union Hospital. Each training lasts about 1.5 days, which includes 1) detailed technique description; 2) prevention and solving of intraoperative complications; 3) live surgery performance; 4) theory and practice of clinical research; 5) comments on trainees' videos; and 6) questions, answers and discussions. In this study, 875 trainees who participated in ATP-LRG from January 2015 to October 2020 were interviewed using electronic questionnaires. Using a repeated-measures design to examine differences in outcomes before and after participating in the training. Questionnaire Star (Changsha Ranxing Information Technology Co., Ltd), a most widely used professional online questionnaire software platform in China, was used to design and create a link to the questionnaire. The questionnaire's link was sent to each trainee via WeChat (Tencent Holdings Limited), the most commonly used social networking software in China.

Conditions

Timeline

Start date
2021-11-11
Primary completion
2021-12-02
Completion
2021-12-20
First posted
2022-02-02
Last updated
2022-05-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05219539. Inclusion in this directory is not an endorsement.